A U.S. bankruptcy judge considering the case of Bondex International Inc. has sided with lawyers representing asbestos claimants, rejecting a method the company used to determine that they owe only about $575 million to those injured by asbestos exposure caused by their products. Instead, the judge says, that figure is closer to $1.17 billion. An article in Bloomberg reports that Bondex, which is a unit of RPM International Incorporated – makers of Rust-Oleum – tried to grossly underestimate their obligations to current and future victims of asbestos exposure . “We decline to accept debtors’ novel approach in this case,” said Judge Judith K. Fitzgerald in her opinion, issued this week. The ruling was made to help determine how much Bondex and its affiliates must attempt to set aside as part of the company’s reorganization plan. After the company filed bankruptcy in 2010, faced with an exorbitant number of asbestos-related claims, it vowed to set up an asbestos victims trust that would address current and future lawsuits against them. By organizing such a trust, the company becomes immune from future lawsuits. The trust provides compensation that victims can use for medical care and other expenses associated with a diagnosis of mesothelioma cancer . Bondex International , originally owned by Reardon, was purchased by Republic Powdered Metals (RPM) in 1966. The company is best known in the United States as the makers of a line of household patching and repair products but also produced dozens of general contractor and home remodeling products including those for surface preparation, wallpapering, texturing, and concrete and masonry repair. Many of these products once contained asbestos though the company no longer uses the mineral in the manufacture of its products.
Read More...Cancer News
- Bladder Cancer (65)
- Brain Tumor Cancer (38)
- Breast Cancer (8038)
- Cancer Bulletins (543)
- Cancer Clinical Trials (5106)
- Cancer Treatment (1201)
- Colon Rectal Cancer (5951)
- General Cancer (16822)
- Leukemia Lymphoma Cancer (10572)
- Lung Mesothelioma Asbestos (4827)
- Ovarian Cervical Uterine Cancer (1137)
- Pancreatic Cancer (56)
- Prostate Cancer (6895)
- Skin Cancer (6030)
- Uncategorized (53)
-
Cancer News Topics
- Cancer and birth defects in Iraq: The nuclear legacy
- New factor to control oncogene-induced senescence discovered
- New tumor-killer shows great promise in suppressing cancers
- Vitamin C can kill drug-resistant TB
- Low radiation scans help identify cancer in earliest stages
- Keeping stem cells strong: RNA molecule protects stem cells during inflammation
- H. pylori, smoking trends, and gastric cancer in US men
- Changing cancer’s environment to halt its spread
- West Michigan Cancer Center expands oncology team, adds Dr. Tolga Tuncer
- Estimate Says Bondex May Owe More than a Billion in Asbestos Claims
- Poliovirus vaccine trial shows early promise for recurrent glioblastoma
- Scientists uncover how grapefruits provide a secret weapon in medical drug delivery
- Radioactive nanoparticles target cancer cells
- Racial disparities seen in U.S. lung cancer treatment
- Ease Cancer Stress, Anxiety with ‘Emotional Wellness Toolbox’
- Asbestos Contributes to Overall Failing Grades of New Jersey School District According to Architect Reports
- How gold nanoparticles can help fight ovarian cancer
- Hong Kong women weigh in on Angelina Jolie’s breast cancer solution
- Focusing on Tumor-Activated Protein May Lead to Personalized Mesothelioma Treatment
- New algorithm maps cancer cells like nodes on a social network
- UK Aims To Make Genetic Testing Available To All Cancer Patients
- Cancer Survivors Suffer Physical & Emotional Impairments Which Often Go Untreated
- Outcome In Head And Neck Cancer Predicted By Genetic Diversity Within Tumors
- Software May Allow Doctors To Track Progression Of Cancer, Response To Treatment, And Risk Of Relapse
- Cancer Cause Directs Treatment 0314.2013-13.23
